Penobscot Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Buy
12,634
+577
+5% +$590K 1.04% 22
2026
Q1
$11.1M Buy
12,057
+35
+0.3% +$35.5K 0.87% 26
2025
Q4
$12.9M Buy
12,022
+77
+0.6% +$73.6K 0.97% 23
2025
Q3
$9.11M Buy
11,945
+1,509
+14% +$1.12M 0.7% 31
2025
Q2
$8.14M Buy
10,436
+869
+9% +$675K 0.7% 32
2025
Q1
$7.9M Buy
9,567
+394
+4% +$328K 0.74% 36
2024
Q4
$7.08M Buy
9,173
+1,343
+17% +$1.11M 0.64% 40
2024
Q3
$6.94M Buy
7,830
+85
+1% +$76.4K 0.62% 42
2024
Q2
$7.01M Buy
7,745
+305
+4% +$244K 0.68% 38
2024
Q1
$5.79M Buy
7,440
+1,060
+17% +$754K 0.61% 44
2023
Q4
$3.72M Buy
6,380
+552
+9% +$322K 0.44% 57
2023
Q3
$3.13M Buy
5,828
+3,143
+117% +$1.62M 0.43% 58
2023
Q2
$1.26M Buy
2,685
+925
+53% +$388K 0.21% 103
2023
Q1
$604K Buy
1,760
+430
+32% +$145K 0.11% 143
2022
Q4
$487K Hold
1,330
0.09% 153
2022
Q3
$430K Hold
1,330
0.08% 156
2022
Q2
$431K Hold
1,330
0.07% 162
2022
Q1
$381K Buy
1,330
+500
+60% +$129K 0.06% 180
2021
Q4
$229K Buy
+830
New +$210K 0.03% 231

Other funds holding LLY

Penobscot Investment Management's LLY Position: Q2 2026 in Review

Penobscot Investment Management increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $590K and bringing the position to 12,634 shares worth $15.2M. The position accounts for 1.04% of the portfolio, ranked #22.

Penobscot Investment Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,568 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Penobscot Investment Management held 12,634 shares of Eli Lilly worth $15.2M as of Q2 2026.
  • Penobscot Investment Management bought 577 Eli Lilly shares in Q2 2026, an estimated $590K.
  • Eli Lilly made up 1.04% of Penobscot Investment Management's portfolio in Q2 2026, its #22 holding.
  • Penobscot Investment Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 1,568 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.